Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
暂无分享,去创建一个
Lena E. Friberg | Apostolos Armaganidis | Konstantinos Pontikis | Diamantis Plachouras | O. Cars | A. Armaganidis | D. Plachouras | A. Antoniadou | H. Giamarellou | L. Friberg | Otto Cars | I. Karaiskos | Helen Giamarellou | Ami F. Mohamed | Ilias Karaiskos | Matti Karvanen | Britt Jansson | Evangelos Papadomichelakis | Anastasia Antoniadou | B. Jansson | E. Papadomichelakis | K. Pontikis | M. Karvanen
[1] W. Couet,et al. Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80‐mg Intravenous Dose of CMS in Young Healthy Volunteers , 2011, Clinical pharmacology and therapeutics.
[2] A. Armaganidis,et al. Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria , 2009, Antimicrobial Agents and Chemotherapy.
[3] E N Jonsson,et al. Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. , 1999, Computer methods and programs in biomedicine.
[4] O. Cars,et al. Pharmacokinetic-Pharmacodynamic Model for Gentamicin and Its Adaptive Resistance with Predictions of Dosing Schedules in Newborn Infants , 2011, Antimicrobial Agents and Chemotherapy.
[5] N. Holford,et al. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. , 2004, British journal of clinical pharmacology.
[6] R. Robinson. Constitution of Strychnine and its Relation to Cinchonine , 1947, Nature.
[7] Phillip J. Bergen,et al. Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model , 2010, Antimicrobial Agents and Chemotherapy.
[8] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[9] O. Cars,et al. Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS. , 2009, Journal of pharmaceutical and biomedical analysis.
[10] J. Turnidge,et al. Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models , 2009, Antimicrobial Agents and Chemotherapy.
[11] N. Uddin,et al. Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital , 2010, Antimicrobial Agents and Chemotherapy.
[12] J. Turnidge,et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. , 2006, The Lancet. Infectious diseases.
[13] P. Marik,et al. Management of sepsis during the early "golden hours". , 2006, The Journal of emergency medicine.
[14] E. Niclas Jonsson,et al. PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM , 2005, Comput. Methods Programs Biomed..
[15] Andrew C. Hooker,et al. Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models , 2011, The AAPS Journal.
[16] J. Turnidge,et al. Simple Method for Assaying Colistin Methanesulfonate in Plasma and Urine Using High-Performance Liquid Chromatography , 2002, Antimicrobial Agents and Chemotherapy.
[17] Neang S. Ly,et al. Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing , 2010, Pharmacotherapy.
[18] P. Honore,et al. Renal and neurological side effects of colistin in critically ill patients , 2011, Annals of intensive care.
[19] White Hj,et al. Polymyxin: a new chemotherapeutic agent. , 1947, Bulletin of the Johns Hopkins Hospital.
[20] G. Iotti,et al. Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. , 2010, Chest.
[21] H. White,et al. Polymyxin: a new chemotherapeutic agent. , 1947, Bulletin of the Johns Hopkins Hospital.
[22] Stephan Harbarth,et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. , 2003, The American journal of medicine.
[23] Matthew E Falagas,et al. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] Lena E. Friberg,et al. Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization , 2011, Antimicrobial Agents and Chemotherapy.
[25] W. Craig,et al. Significance of serum protein and tissue binding of antimicrobial agents. , 1976, Annual review of medicine.
[26] G. Brownlee,et al. ‘Aerosporin’, an Antibiotic Produced by Bacillus aerosporus Greer , 1947, Nature.
[27] Daniel C. Harris,et al. Nonlinear Least Squares Curve Fitting with Microsoft Excel Solver , 1998 .
[28] A Forrest,et al. Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients , 2011, Antimicrobial Agents and Chemotherapy.
[29] M. Falagas,et al. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies , 2006, Critical care.
[30] Mats O. Karlsson,et al. Semimechanistic Pharmacokinetic/Pharmacodynamic Model for Assessment of Activity of Antibacterial Agents from Time-Kill Curve Experiments , 2006, Antimicrobial Agents and Chemotherapy.
[31] K. Kaye,et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] Mats O. Karlsson,et al. Three new residual error models for population PK/PD analyses , 1995, Journal of Pharmacokinetics and Biopharmaceutics.
[33] Mats O Karlsson,et al. Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis. , 2004, British journal of clinical pharmacology.
[34] R. Nation,et al. Evaluating the stability of colistin and colistin methanesulphonate in human plasma under different conditions of storage. , 2010, The Journal of antimicrobial chemotherapy.